These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23094834)

  • 1. Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer.
    Paolino D; Cosco D; Celano M; Moretti S; Puxeddu E; Russo D; Fresta M
    Nanomedicine (Lond); 2013 Feb; 8(2):193-201. PubMed ID: 23094834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response.
    Cosco D; Paolino D; De Angelis F; Cilurzo F; Celia C; Di Marzio L; Russo D; Tsapis N; Fattal E; Fresta M
    Eur J Pharm Biopharm; 2015 Jan; 89():30-9. PubMed ID: 25460850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatible Glycopolymer Nanocapsules via Inverse Miniemulsion Periphery RAFT Polymerization for the Delivery of Gemcitabine.
    Utama RH; Jiang Y; Zetterlund PB; Stenzel MH
    Biomacromolecules; 2015 Jul; 16(7):2144-56. PubMed ID: 26027950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cellular uptake and intracellular drug controlled release of VESylated gemcitabine prodrug nanocapsules.
    Fang Y; Du F; Xu Y; Meng H; Huang J; Zhang X; Lu W; Liu S; Yu J
    Colloids Surf B Biointerfaces; 2015 Apr; 128():357-362. PubMed ID: 25746328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer.
    Cosco D; Bulotta A; Ventura M; Celia C; Calimeri T; Perri G; Paolino D; Costa N; Neri P; Tagliaferri P; Tassone P; Fresta M
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1009-20. PubMed ID: 19263052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereocomplex Prodrugs of Oligo(lactic acid)
    Tam YT; Huang C; Poellmann M; Kwon GS
    ACS Nano; 2018 Jul; 12(7):7406-7414. PubMed ID: 29957934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival.
    Allison Logan S; Brissenden AJ; Szewczuk MR; Neufeld RJ
    Drug Des Devel Ther; 2017; 11():2239-2250. PubMed ID: 28814832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.
    Klippstein R; Wang JT; El-Gogary RI; Bai J; Mustafa F; Rubio N; Bansal S; Al-Jamal WT; Al-Jamal KT
    Small; 2015 Sep; 11(36):4704-22. PubMed ID: 26140363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer.
    Aggarwal S; Yadav S; Gupta S
    J Biomed Nanotechnol; 2011 Feb; 7(1):137-8. PubMed ID: 21485840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
    Zhang R; Ru Y; Gao Y; Li J; Mao S
    Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model.
    Paolino D; Licciardi M; Celia C; Giammona G; Fresta M; Cavallaro G
    Eur J Pharm Biopharm; 2012 Sep; 82(1):94-102. PubMed ID: 22705641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
    Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
    Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells.
    Oliveira C; Neves NM; Reis RL; Martins A; Silva TH
    Nanomedicine (Lond); 2018 Aug; 13(16):2037-2050. PubMed ID: 30189774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy.
    Zhang C; Pan D; Li J; Hu J; Bains A; Guys N; Zhu H; Li X; Luo K; Gong Q; Gu Z
    Acta Biomater; 2017 Jun; 55():153-162. PubMed ID: 28259838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic cancer cells.
    Yu H; Song H; Xiao J; Chen H; Jin X; Lin X; Pan B; Ji W
    Biomed Pharmacother; 2017 Dec; 96():650-658. PubMed ID: 29035831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer.
    Zhao X; Li F; Li Y; Wang H; Ren H; Chen J; Nie G; Hao J
    Biomaterials; 2015 Apr; 46():13-25. PubMed ID: 25678112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infra Red Dye and Endostar Loaded Poly Lactic Acid Nano Particles as a Novel Theranostic Nanomedicine for Breast Cancer.
    Zhang Q; Du Y; Jing L; Liang X; Li Y; Li X; Dai Z; Tian J
    J Biomed Nanotechnol; 2016 Mar; 12(3):491-502. PubMed ID: 27280247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure.
    Moysan E; González-Fernández Y; Lautram N; Béjaud J; Bastiat G; Benoit JP
    Soft Matter; 2014 Mar; 10(11):1767-77. PubMed ID: 24652455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced anticancer activity of gemcitabine coupling with conjugated linoleic acid against human breast cancer in vitro and in vivo.
    Tao XM; Wang JC; Wang JB; Feng Q; Gao SY; Zhang LR; Zhang Q
    Eur J Pharm Biopharm; 2012 Oct; 82(2):401-9. PubMed ID: 22728546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [
    Boyle AJ; Cao PJ; Cai Z; Chan C; Hedley DW; Reilly RM
    Nucl Med Biol; 2020; 84-85():46-54. PubMed ID: 32062317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.